Masimo Personal Health (MASI): חובות להיוון בספרים

Masimo Corporation (MASI) maintains its leadership in the non-contact patient monitoring segment, leveraging proprietary data analysis methods. The company is currently expanding the deployment of its sensors to increase profitability within its core tech division. This price chart shows the metric at 0.58. Financial stability is driven by the sale of consumables for the equipment, which guarantees a steady cash flow regardless of market conditions.

This indicator measures the degree of financial leverage by comparing total liabilities to the market value of equity over time. By analyzing the total debt-to-book capitalization ratio, investors assess the resilience of Masimo Corporation (MASI) to market volatility, which is critical for a non-invasive monitoring leader whose dominance in intensive care units, driven by SET technology, requires stable funding for innovation.